Avgol: What Actually Has to Happen in Mocksville for Margins to Open Up
The main article identified Mocksville as the active bottleneck. This follow-up shows why a line that is already in commercial operation still has not opened the margin story: in 2025 it mainly ran basic products, and the critical next step is product qualification, fuller use of the line’s capabilities, and scaling advanced soft products.
Where The Main Article Stopped, And What This Follow-Up Isolates
The main article argued that Avgol’s bottleneck is no longer demand. It is Mocksville. That is still right, but it leaves one more question open: what exactly separates a line that is already running from a line that is truly releasing margin.
The answer in the filings is fairly sharp: Mocksville has already cleared the construction test, but not yet the qualification test. Toward the end of the first quarter of 2025 the sixth line was defined as ready for commercial operation, the project stayed on schedule at about $90 million, and all supplier payments were completed by year-end. That takes most of the construction risk off the table. The remaining risk is different: since commercial operation began, the line has mainly been producing basic and relatively simple products while only partially using its full capabilities.
That is the core of this continuation. In a nonwovens operation, commercial launch is not the end of the process. It is the start of the proof phase. The company itself says that many hygiene customers have strict production and packaging requirements, and that a producer must prove its ability to meet them before a supply relationship is established. So the path from a working machine to a fully economic machine runs through operating stability, then product qualification, and only then through the mix that truly uses what the line was built to do.
What is already working is clear. In the fourth quarter outputs kept rising, key operating indicators improved, and management explicitly marked the next phase: product qualifications, fuller use of the line’s capabilities, and scaling advanced soft products. What is still missing is also clear: gross profit still does not look like the line is mature.
That chart explains why Mocksville matters so much. The new line adds about 20 thousand tons of annual capacity out of about 98 thousand tons at the U.S. site. In other words, this is roughly one-fifth of the site, not a marginal increment. As long as that fifth is running basic products and only partially using the line’s capabilities, the gap shows up in the consolidated numbers.
Mocksville's Proof Ladder
The company’s own language creates a fairly clear ladder. Not one step, but a sequence that still has to be completed.
| Stage | What has already happened | What is still missing | Why it matters economically |
|---|---|---|---|
| Construction and commercial start | The line was ready for commercial operation toward the end of Q1 2025, on schedule and at about $90 million | This phase is already behind the company | Construction risk is lower, so the engineering excuse is weaker |
| Initial production | Since launch, the line has mainly produced basic and relatively simple products while only partially using its full capabilities | The line still has to move beyond base products toward fuller capability use | Capacity alone is not enough if the mix does not justify it |
| Operating improvement | In Q4 outputs rose gradually and key operating indicators improved | That improvement has not yet fully shown up in gross profit | There is proof that the ramp is moving, but not yet proof that the issue is solved |
| The next phase | Management points to product qualifications, fuller use of capabilities and scaling advanced soft products | This is the stage that still needs to close | This is where the transition from volume to margin is supposed to happen |
The critical row in that table is product qualification. This is not a bureaucratic footnote. It is the gate between a line that can technically produce and a line that can be loaded with the commercially relevant products of major customers. The company itself explains that hygiene customers require proof that the producer can meet strict production and packaging requirements before supply arrangements are made. So one more qualification effectively means one more step that allows volume to rise, mix to broaden, and the line to take on the products it was built for.
This is also where the broader strategic signal appears. The annual report describes a global shift toward softer fabrics and says the company continued developing Bi-Component products that provide unique softness and feel. In the same discussion it states that the new U.S. line has production capability in that technology. That matters because Mocksville’s upside is not just generic tonnage. It is the ability to move from base products toward products that fit both the market direction and the line’s differentiated capabilities.
Why Margins Still Have Not Fully Opened
The most important message in the filings is that profitability does not open the moment a line begins to produce. It opens only when the line does three things at the same time: produces more, produces more stably, and produces the kind of products that justify its technology.
That is visible in the fourth-quarter numbers.
The picture is almost paradoxical. Sales rose to $94.6 million from $91.2 million. Underlying EBITDA rose to $12.6 million from $11.4 million. Sales volume was up 7.9%, and management linked that to an enhanced soft product portfolio, mainly in North America and Asia. So there is real evidence that the new line is already helping volume and supporting some operating improvement.
But that still is not full release. Gross profit fell to $13.0 million from $13.7 million. The presentation explains that sales growth was more than offset by lower operational efficiency in the U.S., partly linked to the new line, along with higher depreciation, higher production costs, duties and FX impact. In plain terms, Mocksville is already producing more, but it is not yet producing cleanly enough for the margin line to respond in full.
That matters because it clarifies what should not be read into the data. It is easy to see a new line, added capacity and rising output and conclude that the hard part is over. That is a mistake. The hard part is the phase in which a new line stops being a new line and becomes a proven line. As long as management is still talking about product qualifications, fuller capability use and scaling more advanced soft products, the line is still climbing its economic learning curve.
Even the group utilization figure can mislead if it is read too quickly. The company reported actual utilization of about 85% of group production capacity in 2025, but in the same breath it makes clear that the new U.S. line only began operating toward the end of Q1 and ran on relatively simple products with only partial use of its capabilities. So 85% at group level is not proof that Mocksville has already reached the operating point it ultimately needs to reach.
What Actually Has To Happen For The Margin To Open
If all the disclosure is compressed into one question, the answer looks like this: Mocksville has to close the distance between installed capacity and proven capacity.
First, the company has to show a visible pace of completed product qualifications. It does not disclose exactly which customers or products have already cleared the process, so the signal will have to come through management language in the next reports: less language about qualifications still ahead, and more language showing that a larger part of the intended product set is already running on the line.
Second, the line has to make real use of its full capabilities. The documents leave little doubt that the new line was built as an advanced line, and the company directly connects it to improved softness and Bi-Component product capability. So the economic gap in 2025 does not come only from the line not being full. It also comes from the line not yet running in the part of the mix where its technological edge is meant to matter.
Third, the operating improvement has to start showing up in gross profit. Q4 already showed better operating indicators and higher underlying EBITDA, but it did not yet show proof at the gross-profit line. That is the key test. As long as sales and output rise faster than margin quality, the line has not finished the move from ramp phase to harvest phase.
Fourth, the company has to prove mix, not only tonnage. The presentation already talks about a soft product portfolio and advanced soft products. That is an important signal because it means management itself is not judging Mocksville only by tons. The real measure is whether those tons come through products that improve the line’s commercial position and operating performance, not through capacity filling at any price.
In that sense, 2026 is not only a proof year for Avgol. It is a proof year for Mocksville specifically. The line is already built, the financing burden is already in the system, and the depreciation is already running through the income statement. What remains is to see whether the qualification and mix layer can convert that into better economics.
Conclusion
Mocksville is no longer a construction project. It is a proof project. The filings lay out a fairly clear path: the line launched on time and on budget, spent 2025 mainly on basic products, showed higher output and better operating indicators in Q4, and now has to pass the critical stage of product qualification, fuller capability use and scaling advanced soft products.
The current thesis: margins in Mocksville will not open because there is more volume. They will open only if that volume arrives after qualification, on a mix that uses the line’s edge, and finally shows up in gross profit as well.
That is the difference between a line that is running and a line that is proven. In 2025 Avgol only made it halfway.